肠道微生物群和肝硬化之间的因果关系:双向的双样本孟德尔随机化分析
Qing-Ao Xiao1,2, Yun-Fei Yang2,3, Lin Chen2,4
1Department of Interventional Radiology, The First College of Clinical Medical Science, China Three Gorges University, Yichang, China.
Frontiers in microbiology
|November 3, 2023
概括
这项研究使用了门德尔的随机化来研究肠道微生物和肝硬化之间的因果关系. 某些肠道细菌,如拉克诺斯皮拉氏菌 (Lachnospiraceae),可能会伤害肝硬化,而其他细菌,如Erysipelatoclostridium,可能会预防肝硬化.
科学领域:
- 微生物学 微生物学
- 遗传学 是一个遗传学.
- 胃肠病学 胃肠病学
背景情况:
- 肠道微生物群和肝硬化之间的关系是已知的,但因果关系仍然不确定.
- 了解这种联系对于开发肝脏疾病的新治疗策略至关重要.
研究的目的:
- 通过双向孟德尔随机化 (MR) 来研究肠道微生物群和肝硬化之间的潜在因果关系.
- 为了识别可能影响肝硬化发展或进展的特定肠道微生物.
主要方法:
- 利用了针对肝硬化和肠道微生物的大规模基因组广泛协会研究 (GWAS) 的数据.
- 使用双样本和双向门德尔随机化 (MR) 分析来评估因果关系及其方向.
主要成果:
- 确定了21种可能与肝硬化相关的肠道微生物和11种在肠道微生物群中的遗传责任.
- 发现Lachnospiraceae家族可能有害 (OR:1.59) 和Erysipelatoclostridium属可能保护 (OR:0.55) 肝硬化.
- 确定了Butyricicoccus属和初级胆道胆道炎 (PBC) 之间的双向因果关系.
结论:
- 提供了关于特定肠道微生物群和肝硬化之间因果关系的新证据.
- 突出了肠道微生物群在肝硬化病变和进展中的重要作用,提供了新的治疗点.
相关概念视频
Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...


